NCT03021239View on ClinicalTrials.gov

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Continous Flow Left Ventricular Device
Interventions
PROCEDURE

Echo Guided Testing

PROCEDURE

Hemodynamic-Echo Ramp Testing -

Trial Locations (8)

Unknown

UC San Diego Medical Center, San Diego

Stanford Medical Center, Stanford

Northwestern University, Chicago

The University of Chicago, Chicago

Montefiore Medical Center, The Bronx

Hospital of the University of Pennsylvania, Philadelphia

University of Pittsburgh Medical Center, Pittsburgh

University of Washington School of Medicine, Seattle

All Listed Sponsors
lead

University of Chicago

OTHER

NCT03021239 - Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life | Biotech Hunter | Biotech Hunter